Trial intelligence / Profile preview

Alvimopan for postoperative gastrointestinal function recovery after bowel resection with primary anastomosis

CTR20150374Phase 2Suspended

Sponsor
Sunshine Novo
Start
Jun 2015
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of alvimopan in postoperative ileus (POI), sponsored by Sunshine Novo. Started Jun 2015; status: suspended.

02

Drugs

alvimopan
03

Conditions

postoperative ileus (POI)

Beyond the preview

Go deeper on CTR20150374.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on CTR20150374.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call